Beacon Pointe Advisors, LLC

SEC CIK: 0001744317
Latest filing: Aug 18, 2026

SEC filings (opens in a new tab)

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Beacon Pointe Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overview All 13F holders of REGN Full Q2 2026 holdings

Shares (Q2 2026): 19,460
Value: $12.1M
% of portfolio: 0.1%
Quarters held: 21; Since Q2 2021

Holdings of REGN by Beacon Pointe Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	19,460	$12.1M	0.1%	00.0%	Unchanged	Holders
Q1 2026	19,460	$15.0M	0.1%	+7,396+61.3%	Added	Holders
Q4 2025	12,064	$9.31M	0.1%	−147−1.2%	Reduced	Holders
Q3 2025	12,211	$6.87M	0.1%	−7,256−37.3%	Reduced	Holders
Q2 2025	19,467	$10.2M	0.1%	−48−0.2%	Reduced	Holders
Q1 2025	19,515	$12.4M	0.1%	−161−0.8%	Reduced	Holders
Q4 2024	19,676	$14.0M	0.2%	−425−2.1%	Reduced	Holders
Q3 2024	20,101	$21.1M	0.2%	−2,169−9.7%	Reduced	Holders
Q2 2024	22,270	$23.4M	0.3%	−330−1.5%	Reduced	Holders
Q1 2024	22,600	$21.8M	0.2%	−186−0.8%	Reduced	Holders
Q4 2023	22,786	$20.0M	0.2%	−1,045−4.4%	Reduced	Holders
Q3 2023	23,831	$19.6M	0.2%	+1,259+5.6%	Added	Holders
Q2 2023	22,572	$16.2M	0.3%	−2,207−8.9%	Reduced	Holders
Q1 2023	24,779	$20.4M	0.3%	−7,144−22.4%	Reduced	Holders
Q4 2022	31,923	$23.0M	0.4%	+4,210+15.2%	Added	Holders
Q3 2022	27,713	$19.1M	0.4%	−338−1.2%	Reduced	Holders
Q2 2022	28,051	$16.6M	0.4%	−499−1.7%	Reduced	Holders
Q1 2022	28,550	$19.9M	0.3%	+3,603+14.4%	Added	Holders
Q4 2021	24,947	$15.8M	0.4%	−4,104−14.1%	Reduced	Holders
Q3 2021	29,051	$17.6M	0.4%	+21,898+306.1%	Added	Holders
Q2 2021	7,153	$4.00M	0.1%	+7,153	New	Holders